The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue SUPPL. 1, 2001, Pages

  Hollenberg, Norman K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ACE inhibition AT1 receptor antagonists; Hyperglycaemia; Intrarenal renin; Renin state

Indexed keywords

EID: 0005347785     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/14703203010020013101     Document Type: Review

References (20)

1. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD.The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
2. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of therapy on the kidney in patients with diabetes:A meta-regression analysis. Ann Intern Med 1993;118:129-38.
3. Hollenberg NK, Raij L. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy. Arch Intern Med 1993;153:2426-35.
4. Ichikawa I. Will Ang II receptor antagonists be renoprotective in humans? Kidney Intern 1996;50:684-92.
5. 1-receptor blockers, and the kidney. E Ritz (Ed) Nephrol Dial Transplant 1997;12: 381-3.
6. Hollenberg NK, Fisher NK. Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word? Hypertension 1995;26: 602-9.
7. Roman RJ, Kaldunski ML, Scicli AG, Carretero OA. Influence of kinins and angiotensin II on the regulation of papillary blood flow. Am J Physiol 1988;255:F690-F698.
8. Price DA, De'Oliveira JM, Fisher NDL, Hollenberg NK. Renal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men. Hypertension 1997;39:240-6.
9. Price DA, Porter LE, Gordon M et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999;10:2382-91.
10. Christlieb AR, Kaldany A, D'Elia JA. Plasma renin activity and hypertension in diabetes mellitus. Diabetes 1976;25:969-74.
11. Bjorck S. The renin-angiotensin system in diabetes mellitus: a physiological and therapeutic study. Scand J Urol Nephrol Suppl 1990;126:1-50.
12. Lush DJ, King JA, Fray JCS. Pathophysiology of low renin syndromes: sites of renal renin secretory impairment and prorenin overexpression. Kidney Int 1993;43:983-99.
13. Weidmann P, Ferrari P, Shaw SG. Renin in Diabetes Mellitus. In: JIS Robertson and MG Nicholls (Ed). The Renin-Angiotensin System. New York: Raven Press, 1991; Chapter 75; 75.1-75.26.
14. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH. The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 1994;45:403-10.
15. Kikkawa R, Kitamura E, Fujiwara Y, Haneda M, Shigeta Y Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats. Renal Physiol 1986;9:187-92.
16. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional immunohistochemical, and molecular biological correlations. Am J Physiol 1993;265:F477-F486.
17. De'Oliveira JM, Price DA, Fisher NDL et al. Autonomy of the renin system in type II diabetes mellitus: Dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney International 1997;52:771-7.
18. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Effect of hyperglycemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci 1996;90:189-95.
19. Osei SY, Price DA, Fisher NDL, Porter LE, Laffel LMB, Hollenberg NK. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans. Hypertension 1999;3:559-64.
20. Osei SY, Price DA, Laffel LMB, Lansang MC, Hollenberg NK. Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans. Hypertension 2000;36:122-6.